losartan has been researched along with methanol in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Strassburg, CP; Tukey, RH | 1 |
Raju, SS; Rao, RN; Sankar, GG; Vali, RM | 1 |
Di, X; Liu, Y; Mao, Z; Wang, X; Wu, Y | 1 |
Batista, JM; da Silva, WM; de Sousa, EMB; Diniz, MLV; Fernandes, C; Glória, MBA | 1 |
1 review(s) available for losartan and methanol
Article | Year |
---|---|
Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
Topics: Autoimmunity; Chromosome Mapping; Glucuronides; Glucuronosyltransferase; Humans; Hyperbilirubinemia; Neoplasms; Steroids; Terminology as Topic | 2000 |
3 other study(ies) available for losartan and methanol
Article | Year |
---|---|
Liquid chromatography-mass spectrometric determination of losartan and its active metabolite on dried blood spots.
Topics: Animals; Chromatography, Liquid; Dried Blood Spot Testing; Drug Stability; Linear Models; Losartan; Methanol; Rats; Reproducibility of Results; Sensitivity and Specificity; Tandem Mass Spectrometry | 2012 |
Simultaneous determination of febuxostat and its three active metabolites in human plasma by liquid chromatography-tandem mass spectrometry and its application to a pharmacokinetic study in Chinese healthy volunteers.
Topics: Acetonitriles; Area Under Curve; Calibration; China; Chromatography, Liquid; Febuxostat; Formates; Healthy Volunteers; Humans; Limit of Detection; Linear Models; Losartan; Methanol; Quality Control; Reproducibility of Results; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry | 2015 |
Boron nitride nanotubes for extraction of angiotensin receptor blockers from human plasma.
Topics: Angiotensin Receptor Antagonists; Antihypertensive Agents; Boron Compounds; Chromatography, High Pressure Liquid; Humans; Losartan; Methanol; Nanotubes; Silicon Dioxide; United States; Valsartan | 2022 |